Patents by Inventor Julie Beth Stimmel

Julie Beth Stimmel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of an anti-EP-CAM antibody with a chemotherapeutic agent
    Patent number: 7939074
    Abstract: A combination of an anti-Ep-CAM antibody with a chemotherapeutic agent that is capable of arresting Ep-CAM antigen expressing cells in S or G2/M.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: May 10, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Vincent C. Knick, Julie Beth Stimmel, Linda M. Thurmond
  • Combination of an Anti-Ep-CAM Antibody with a Chemotherapeutic Agent
    Publication number: 20100172903
    Abstract: A combination of an anti-Ep-CAM antibody with a chemotherapeutic agent that is capable of arresting Ep-CAM antigen expressing cells in S or G2/M.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 8, 2010
    Inventors: Vincent C. Knick, Julie Beth Stimmel, Linda M. Thurmond
  • Combination of anti-EP-CAM antibody with a chemotherapeutic agent
    Patent number: 7648703
    Abstract: A combination of an anti-Ep-CAM antibody with a chemotherapeutic agent that is capable of arresting Ep-CAM antigen expressing cells in S or G2/M.
    Type: Grant
    Filed: January 13, 2005
    Date of Patent: January 19, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Vincent C. Knick, Julie Beth Stimmel, Linda M. Thurmond
  • Use of FXR ligands
    Patent number: 6984650
    Abstract: The present invention includes nuclear receptor heterodimer and nuclear receptor-coactivator peptide assays for identifying ligands for nuclear receptors, utilizing scintillation proximity and fluorescence resonance energy transfer (FRET), and methods of using identified ligands.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: January 10, 2006
    Assignee: Smithkline Beecham Corporation
    Inventors: Curt Dale Haffner, Patrick Reed Maloney, Timothy Mark Willson, Steven Gerard Blanchard, Steven A. Kliewer, Jurgen M. Lehmann, Derek James Parks, Julie Beth Stimmel
  • Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
    Publication number: 20030138430
    Abstract: Pharmaceutical combinations comprising an agent that arrests target cells in the G2 and/or M phase of the cell cycle and another therapeutic agent that targets an internalising cell surface structure such as an antigen. Use in the manufacture of a medicament and in methods of medical treatment, particularly in the treatment of diseases of cell cycle regulation such as cancer are disclosed.
    Type: Application
    Filed: September 20, 2002
    Publication date: July 24, 2003
    Inventors: Julie Beth Stimmel, Linda Margarite Thurmond, Vincent Clark Knick